Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis: A Phase 2 Randomized Clinical Trial von Gooderham, Melinda J, Forman, Seth B, Bissonnette, Robert, Beebe, Jean S, Zhang, Weidong, Banfield, Chris, Zhu, Linda, Papacharalambous, Jocelyne, Vincent, Michael S, Peeva, Elena

Volltext

Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study von Guttman-Yassky, Emma, Silverberg, Jonathan I., Nemoto, Osamu, Forman, Seth B., Wilke, August, Prescilla, Randy, de la Peña, Amparo, Nunes, Fabio P., Janes, Jonathan, Gamalo, Margaret, Donley, David, Paik, Jim, DeLozier, Amy M., Nickoloff, Brian J., Simpson, Eric L.

Volltext

TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial von Forman, Seth B., Pariser, David M., Poulin, Yves, Vincent, Michael S., Gilbert, Steven A., Kieras, Elizabeth M., Qiu, Ruolun, Yu, Dahong, Papacharalambous, Jocelyne, Tehlirian, Christopher, Peeva, Elena

Volltext

Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies von Papp, Kim, Szepietowski, Jacek C., Kircik, Leon, Toth, Darryl, Eichenfield, Lawrence F., Forman, Seth B., Kuligowski, Michael E., Kallender, Howard, Sun, Kang, Ren, Haobo, Simpson, Eric L.

Volltext

Quantification of melanocytes in sun-damaged skin von Madden, Katherine, BA, Forman, Seth B., MD, Elston, Dirk, MD

Volltext

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial von Zirwas, Matthew J, Draelos, Zoe D, DuBois, Janet, Kircik, Leon H, Moore, Angela Y, Stein Gold, Linda, Alonso-Llamazares, Javier, Bukhalo, Michael, Bruce, Suzanne, Eads, Kimmie, Green, Lawrence J, Guenthner, Scott T, Ferris, Laura K, Forman, Seth B, Kempers, Steven E, Lain, Edward, Lynde, Charles W, Pariser, David M, Toth, Darryl P, Yamauchi, Paul S, Higham, Robert C, Krupa, David, Burnett, Patrick, Berk, David R

Volltext

Insights into adult atopic dermatitis heterogeneity derived from circulating biomarker profiling in patients with moderate‐to‐severe disease von Sims, Jonathan T., Chang, Ching‐Yun, Higgs, Richard E., Engle, Sarah M., Liu, Yushi, Sissons, Sean E., Rodgers, George H., Simpson, Eric L., Silverberg, Jonathan I., Forman, Seth B., Janes, Jonathan M., Colvin, Stephanie C., Guttman‐Yassky, Emma

Volltext

33460 Roflumilast foam 0.3% treatment of seborrheic dermatitis is effective and safe and improves patient quality of life: Results from a phase 2 study von Draelos, Zoe D., Forman, Seth B., Green, Lawrence J.

Volltext

Clear-cell basal cell carcinoma : Differentiation from other clear-cell tumors von FORMAN, Seth B, FERRINGER, Tammie C

Volltext

Collision tumor composed of Merkel cell carcinoma and lentigo maligna melanoma von Forman, Seth B., Vidmar, Dennis A., Ferringer, Tammie C.

Volltext

Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo von Rosmarin, David, Passeron, Thierry, Pandya, Amit G., Grimes, Pearl, Harris, John E., Desai, Seemal R., Lebwohl, Mark, Ruer-Mulard, Mireille, Seneschal, Julien, Wolkerstorfer, Albert, Kornacki, Deanna, Sun, Kang, Butler, Kathleen, Ezzedine, Khaled

Volltext

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial von Aronne, Louis J, Sattar, Naveed, Horn, Deborah B, Bays, Harold E, Wharton, Sean, Lin, Wen-Yuan, Ahmad, Nadia N, Zhang, Shuyu, Liao, Ran, Bunck, Mathijs C, Jouravskaya, Irina, Murphy, Madhumita A

Volltext

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, doubl... von Papp, K., Gottlieb, A., Reich, K., Maari, C., Gordon, K.B., Lima, R.G., Elmaraghy, H., Gallo, G., Renda, L., Park, S.Y., Burge, R., Bagel, J., Vender, Ronald, Hong, Chih‐Ho, Langley, Richard L., Albrecht, Lorne, Guenther, Lyn, Papp, Kim, Singh Ohson, Kamal K., Barber, Kirk, Lynde, Charles, Gupta, Aditya, Rosoph, Leslie, Gauthier, Jean‐Sébastien, Gooderham, Melinda, Wasel, Norman, Wiseman, Marni, Greenstein, David, Jarell, Abel, Moon, Charles, Bukhalo, Michael, Moore, Angela, Hamilton, Tiffani K., Gewirtzman, Aron, Hazan, Lydie, Crowley, Jeffrey, Teller, Craig, Smith, Stacy R., Christine Lee, M., Lee, Patricia, Dhawan, Sunil, Leonardi, Craig, Jesus, Amarilis Perez‐De, McFalda, Wendy, Fretzin, Scott, Schlesinger, Todd, Gottlieb, Scott, Jenkin, Peter, Gharib, Rola, Davis, Steven, Draelos, Zoe Diana, Godwin, Lloyd, Landis, Megan, Sanchez‐Rivera, Samuel, Fivenson, David, Kerdel, Francisco, Forman, Seth B., Gonzalez‐Chavez, Jose, Boyce, Brent, Stein‐Gold, Linda, Hudson, Charles, Brown, Constance, Coggi, James, Feser, Christina, McCune, Mark, Madkan, Vandana, Shipp, Dana Maxwell, Soto‐Raices, Oscar, Cather, Jennifer, Miller, Scott, Scott, John, Young, Douglas, Yokum, Kelley, McCracken, Gary, McElgunn, Patrick, Herrmann, James, Appel, James, Barranco, Elizabeth, Cauthen, Ashley, Sadick, Neil, De La Torre, Eneida, Taylor, Kelly, Harris, Holly Hake, Soung, Jennifer, Dimitropoulos, Vassilios, Miller, Stephen, Barnes, Cathy, Jumean‐Haddad, Rawan, Guenthner, Scott, Laquer, Vivian, Jacobs, Shahram, Nahm, Walter, Korman, Neil, Elewski, Boni, Ferris, Laura, Duffin, Kristina Callis, Pariser, David, Johnson, Brian, Travers, Jeffrey, Fried, Richard

Volltext

54147 Efficacy of Ruxolitinib Cream for Treatment of Atopic Dermatitis in Children Aged 2–<12 Years by Baseline Clinical Characteristics: Subgroup Analysis From a Randomized Phase... von Armstrong, April W., Eichenfield, Lawrence F., Lee, Lara Wine, Brar, Kanwaljit K., Joyce, Joel C., Forman, Seth B., Soong, Weily, Sofen, Howard, Angel, Brett, Li, Qian, Stein Gold, Linda F.

Volltext

27716 Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by baseline clinical characteristics: Pooled subgroup analysis from two randomized phase 3 studies von Papp, Kim, Szepietowski, Jacek C., Kircik, Leon, Toth, Darryl, Eichenfield, Lawrence F., Forman, Seth B., Thaçi, Diamant, Kuligowski, Michael E., Venturanza, May E., Sun, Kang, Simpson, Eric L.

Volltext

27496 Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by baseline patient demographics: Pooled subgroup analysis from two randomized phase 3 studies von Papp, Kim, Szepietowski, Jacek C., Kircik, Leon, Toth, Darryl, Eichenfield, Lawrence F., Forman, Seth B., Armstrong, April W., Kuligowski, Michael E., Venturanza, May E., Sun, Kang, Simpson, Eric L.

Volltext

Success of omalizumab as monotherapy in adult atopic dermatitis : Case report and discussion of the high-affinity immunoglobulin E receptor, FcεRI von FORMAN, Seth B, GARRETT, Algin B

Volltext

Lichen Spinulosus: Excellent Response to Tretinoin Gel and Hydroactive Adhesive Applications von Forman, Seth B, Hudgins, E. Mac, Blaylock, W. Kenneth

Volltext

PENILE GRANULOMA ANNULARE OF AN ADOLESCENT MALE : CASE REPORT AND REVIEW OF THE LITERATURE. Discussion von FORMAN, Seth B, SUMFEST, Joel M, PRIDE, Howard B, FERRINGER, Tammie C

Volltext

Success of omalizumab as monotherapy in adult atopic dermatitis: case report and discussion of the high-affinity immunoglobulin E receptor, FcepsilonRI von Forman, Seth B, Garrett, Algin B

Volltext